Last reviewed 2026-04-23 · How we verify

Follitropin beta injection

Stimulates the production of follicle-stimulating hormone (FSH)

Stimulates the production of follicle-stimulating hormone (FSH) Used for Induction of ovulation in anovulatory infertile women, Assisted reproductive technology.

At a glance

Mechanism of action

Follitropin beta injection is a recombinant DNA-derived human follicle-stimulating hormone (hFSH) used to stimulate follicular growth in the ovaries.

Approved indications

• Induction of ovulation in anovulatory infertile women, Assisted reproductive technology

Common side effects

• Ovarian hyperstimulation syndrome
• Headache
• Nausea

Key clinical trials

• A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) (PHASE3)
• Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation. (PHASE3)
• A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants (PHASE1)
• Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers (PHASE1)
• A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (PHASE3)
• PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study (PHASE4)
• Ovarian Hyperstimulation and Fibrin Clot Properties. (NA)
• Continuous Double Ovarian Stimulation. (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.